Rechte & Gesellschaft
EMA Consults on Reducing Animal Testing
The European Medicines Agency (EMA) is consulting on the use of virtual control groups to help reduce animal testing in medicines development. This draft qualification opinion for a new methodology in preclinical research aims to reduce the overall number of animals used. This initiative reflects a growing ethical concern and scientific drive to find alternative testing methods, potentially accelerating drug development while upholding animal welfare standards. It impacts how new medicines are developed and approved in the EU.
EMA seeks to reduce animal testing by using virtual control groups in drug development.